Deniz: The electronic database for β-thalassemia mutations in the Arab world

Saudi Medical Journal

Volumn 24, Issue 11, 2003, Pages 1192-1198

  Tadmouri, Ghazi O ^a   Gulen, Resul I ^a  

^a FATIH UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GLOBIN;

ARAB; ARTICLE; BETA THALASSEMIA; CHROMOSOME ANALYSIS; COMPUTER LANGUAGE; CULTURAL ANTHROPOLOGY; DATA BASE; DENIZ; GENE FREQUENCY; GENE MUTATION; HUMAN COMPUTER INTERACTION; HYPERMEDIA; INCIDENCE; LABORATORY; PREDICTION; STATISTICAL ANALYSIS;

ALLELES; ARABS; BETA-THALASSEMIA; DATABASES, GENETIC; GENE FREQUENCY; GLOBINS; HUMANS; INTERNET; MIDDLE EAST; MUTATION;

EID: 0348133628     PISSN: 03795284     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Luscombe NM, Greenbaum D, Gerstein M. What is bioinformatics? In: Haux R, Kulikowski C, editors. Yearbook of Medical Informatics 2001. Stuttgart (Germany): Schattauer Publishing Company; 2001. p. 83-99.
2. Bergeron B. Bioinformatics Computing. New Jersey (USA): Pearson Education; 2003.
3. The World Health Organization. Community control of hereditary anemias: Memorandum from a WHO meeting. Bull WHO 1983; 61: 63-80.
4. Huisman THJ, Carver MFH, Baysal E. A syllabus of thalassemia mutations (1997). Augusta (USA): The Sickle Cell Anemia Foundation; 1997.
5. Tadmouri GO. A molecular investigation of beta-thalassemia in the district of Istanbul: Application to prenatal diagnosis [dissertation]. Istanbul (Turkey): Bogazici Univ.; 1994.
6. Tadmouri GO. β-Thalassemia in Turkey: Distribution, diversity, evolution and genotype-phenotype correlations [dissertation]. Istanbul (Turkey): Bogazici Univ.; 1999.
7. The National Center for Biotechnology Information (USA). The NCBI Handbook. Bethesda (USA): NCBI; 2003.
8. El-Kalla S, Mathews ARA. Significant β-thalassemia heterogeneity in the United Arab Emirates. Hemoglobin 1997; 21: 237-247.
9. Chehab FF, Der Kaloustian V, Khouri FP, Deeb SS, Kan YW. The molecular basis of β-thalassemia in Lebanon: Application to prenatal diagnosis. Blood 1987; 69: 1141-1145.
10. Zahed L, Qatanani M, Nabulsi M, Taber A. β-Thalassemia mutations and haplotype analysis in Lebanon. Hemoglobin 2000; 24: 269-276.
11. Hardison R, Riemer C, Chui DHK, Huisman THJ, Miller W. Electronic access to sequence alignments, experimental results, and human mutations as an aid to studying globin gene regulation. Genomics 1998; 47: 429-437.
12. Deyde VM, Lo BB, Khalifa IO, Ly B, Ball A, Fattoum S. Epidemiological profile of hemoglobinopathies in the Mauritian population. Ann Hematol 2002; 81: 320-321.
13. Jain RC. Sickle cell and thalassaemic genes in Libya. Trans R Soc Trop Med Hyg 1985; 79: 132-133.
14. Bayoumi RA, Abu Zeid YA, Abdul Sadig A, Awad Elkarim O. Sickle cell disease in Sudan. Trans R Soc Trop Med Hyg 1988; 82: 164-168.
15. Al-Mondhiry H, Al-Hilali A. Severe anemia. Clinical observations in 100 patients with very low hemoglobin levels. Arch Intern Med 1979; 139: 1053-1054.
16. Zahed L, Demont J, Bouhass R, Trabuchet G, Hanni C, Zalloua P et al. Origin and history of the IVS-I-110 and codon 39 β-thalassemia mutations in the Lebanese population. Hum Biol 2002; 74: 837-847.
17. Tadmouri GO, Garguier N, Demont J, Perrin P, Basak AN. History and origin of β-thalassemia in Turkey: Sequence haplotype diversity of β-globin genes. Hum Biol 2001; 73: 661-674.
18. Perrin P, Bouhassa R, Mselli L, Garguier N, Nigon VM, Bennani C et al. Diversity of sequence haplotypes associated with β-thalassemia mutations in Algeria: Implications for their origin. Genet 1998; 213: 169-177.
19. Flint J, Harding RM, Clegg JB, Boyce AJ. Why are some genetic diseases common? Distinguishing selection from other processes by molecular analysis of globin gene variants. Hum Genet 1993; 91: 91-117.
20. Chifu Y, Nakashima H, Hara H, Yokota E, Imamura T. β-Thalassemia major resulting from a compound heterozygosity for the β-globin gene mutation: Further evidence for multiple origin and migration of the thalassemia gene. Hum Genet 1992; 89: 343-346.